Early plasma elevations of HMGB1 were also associated with some clinical outcomes, including GCS, ISS, SIRS, blood base deficit, coagulopathy, and fresh frozen plasma and fluid resuscitation requirements. The gene discussed is HMGB1; the disease is blood coagulation disease.